Providence Medical Research Center :: ASD2 (Atrial Spetal Defect) PMS

You Are Here: Home

Areas of Research

Cardiology

Study Keyword Search

ASD2 (Atrial Spetal Defect) PMS

Primary Investigator:
Carl Garabedian MD

Description:

The purpose of this study is to gather more information about how effective the Amplatzer Septal Occluder is at closing an atrial septal defect. Atrial septal defect (ASD) is a congenital (occurring at birth) heart defect in which the wall that separates the upper heart chambers (atria) does not close completely. The study is also being done to collect information about the safety of the device. The study is being conducted at up to 30 medical centers across the United States.

Eligibility:

Appropriate candidate for an implant with the AMPLATZER Septal Occluder.

Willing to complete the follow up requirements of the study

Please contact study coordinator for more information about whether you qualify for this study.

Exclusions:

Serious infections within one month prior to procedure.

Bleeding disorders, untreated ulcer, unable to take aspirin

There may be other conditions that could keep you from being in this study. Please contact study coordinator.

Study Timeline:
Currently Enrolling

Study Contact:
Joan Milton MS RD Joan.E.Milton@providence.org

Study Sponsor:
Amplatzer

Keywords :